Clinical Trials

Inclusion Criteria:

• Written informed consent and HIPAA authorization.
• At least 18 years of age.
• Recipient of a primary or subsequent deceased-donor or living-donor kidney transplant.
• At least 1-year post-transplant (+/- 2 months).
• Stable serum creatinine (current serum creatinine < 2.3 mg/dl, < 20% increase compared to the average of the previous 3 serum creatinine levels).
• Treated with any immunosuppressive regimen.
• Selected by provider to undergo TruGraf® and TRAC™ testing as part of post-transplant care.
• Has Medicare Part B coverage or private insurance

Exclusion Criteria:

• Recipient of a combined organ transplant with an extra-renal organ and/or islet cell transplant.
• Recipient of a previous non-renal solid organ and/or islet cell transplant.
• Known to be pregnant.
• Known to be infected with Human Immunodeficiency Virus (HIV).
• Known to have BK nephropathy.
• Known to have nephrotic proteinuria (urine protein > 3 gm/day).